WHO ICTRP trial
Efficacy and safety of a novel photosensitiser, hemoporfin in photodynamic…
ChiCTR-TRC-08000236 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-08000236 |
|---|---|
| Public title | Efficacy and safety of a novel photosensitiser, hemoporfin in photodynamic therapy for port-wine stain: a randomized, multicentre, double-blind, placebo-controlled, parallel group phase IIb study |
| Scientific title | Efficacy and safety of a novel photosensitiser, hemoporfin in photodynamic therapy for port-wine stain: a randomized, multicentre, double-blind, placebo-controlled, parallel group phase IIb study |
| Primary sponsor | Peking University First Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | II (Phase II study) |
| Countries | China |
| Conditions | port-wine stain |
| Interventions | 20 minutes group:madication with laser 20 minutes;30 minutes group:madication with laser 30 minutes |
| Registration date | Dec 15, 2008 |
| Target size | 20 minutes group:20;30 minutes group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: